Drug intelligence / Profile preview

Phytus

Development stage
Phase 4
Lead developer
PharmEvo
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Phytus is a botanical combination product containing extracts of Ivy (Hedera helix), Thyme (Thymus vulgaris), and Cisti (Cistus incanus), developed by PharmEvo for the treatment of acute cough. The therapeutic effect is derived from the synergistic actions of its components: Ivy extract provides secretolytic and bronchospasmolytic activity, primarily by inhibiting the internalization of Beta-2 adrenergic receptors; Thyme extract offers antitussive, secretomotor, and antimicrobial properties; and Cistus extract contributes antiviral and antioxidant effects. Phytus is typically administered orally as a solution and has been evaluated in Phase 3 clinical trials to demonstrate its efficacy in reducing the severity and duration of cough symptoms associated with respiratory infections.

Brand names
Phytus
Other names
Ivy, Thyme and Cisti ExtractPEACe
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Phytus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call